Only 1 active COVID-19 case left in Olongapo City | Inquirer News

Only 1 active COVID-19 case left in Olongapo City

/ 11:53 AM December 15, 2021

Olongapo City, COVID-19

The number of COVID-19 cases in Olongapo City is improving as it moves closer to being virus-free again. (File photo by Joanna Rose Aglibot)

OLONGAPO CITY––Four more patients here have recovered from COVID-19, leaving the city with a single active case, local data showed on Tuesday, Dec. 14.

The city did not record new infections, keeping its total tally at 5,457 since the pandemic began last year.

ADVERTISEMENT

For three consecutive days, the city did not record a new COVID-19 case. No deaths were recorded on Monday and in the past two days.

FEATURED STORIES

With 5,139 patients getting cleared of the viral disease, the city’s recovery rate stood at 94 percent.

So far, 152,693 residents, or 84 percent of the target population, had been inoculated the first dose of the vaccine against COVID-19. At least 113,735 residents or 58 percent had been fully vaccinated, including those who received the single-shot Janssen vaccine.

The city aims to inoculate 182,000 residents or 70 percent of its 260,000-population to achieve herd immunity against COVID-19.

lzb
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Olongapo City, Regions

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.